Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of BCG Re-vaccination on Malaria Morbidity
NCT00131794Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jan 2003
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of bcg vaccine in malaria (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Incidence of clinical malaria. Started Jan 2003; status: completed.
02
Drugs
bcg vaccine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00131794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00131794.